These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38504462)

  • 1. Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
    Campbell F; Laws P
    Br J Dermatol; 2024 Jul; 191(2):163. PubMed ID: 38504462
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of significant liver fibrosis in Chinese psoriasis patients receiving methotrexate: a comparison between transient elastography and liver histology.
    Wong CSM; Mak LLY; Lee VKH; Lo RCL; Chung MMH; Chu F; Yeung CK; Yuen MF; Chan HHL
    Hong Kong Med J; 2024 Apr; 30(2):110-119. PubMed ID: 38651202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis.
    Affleck A; Goudie A; Smith R
    Clin Exp Dermatol; 2019 Jul; 44(5):591-592. PubMed ID: 30919996
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in psoriasis: consensus conference.
    Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate hepatotoxicity: what is the evidence?
    Ahern MJ; Smith MD; Roberts-Thomson PJ
    Inflamm Res; 1998 Apr; 47(4):148-51. PubMed ID: 9628257
    [No Abstract]   [Full Text] [Related]  

  • 8. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
    Mathew J; Leong MY; Morley N; Burt AD
    BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis, transient elastography and methotrexate: monitoring at a tertiary hospital.
    Koch K
    Australas J Dermatol; 2021 Feb; 62(1):69-70. PubMed ID: 32700316
    [No Abstract]   [Full Text] [Related]  

  • 11. Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.
    van den Reek JMPA; Menting SP; Janssen WWL; Dhaliwal R; Heijboer AC; van Herwaarden AE; Sweep FCGJ; de Jong LM; Tjwa ET; Otero ME; Spuls PI; de Jong EMGJ
    Br J Dermatol; 2017 Nov; 177(5):1454-1457. PubMed ID: 28112796
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
    Bray AP; Barnova I; Przemioslo R; Kennedy CT
    Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate use and liver disease--a causal relationship?
    Schmitt J; Singh JA
    Br J Dermatol; 2014 Jul; 171(1):6-7. PubMed ID: 25066285
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography.
    Mahajan R; Dogra S; Handa S; Razmi TM; Narang T; Rathi S; Dhiman RK; Saikia B; Karim A
    Indian J Dermatol Venereol Leprol; 2020; 86(6):649-655. PubMed ID: 32643632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.
    Babakinejad P; Lapsley R; Forster L; McPherson S; Pearce MS; Reynolds NJ; Slack E; Weatherhead SC; Hampton PJ
    Br J Dermatol; 2024 Jul; 191(2):275-283. PubMed ID: 38366967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on psoriasis at the Dermatology Day conference, Paris 2010].
    Battistella M; Boulinguez S
    Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H1-10. PubMed ID: 21703456
    [No Abstract]   [Full Text] [Related]  

  • 17. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC; Menter MA
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute liver failure in a patient with methotrexate therapy].
    Penalva Polo JC; Gómez Andrés A; Vela P; Niveiro M
    Rev Esp Enferm Dig; 2002 Jul; 94(7):440-1. PubMed ID: 12432845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.